Literature DB >> 14379004

Poliomyelitis Lansing antibodies in three population groups in Israel.

H BERNKOPF, S LEVINE.   

Abstract

A study has been made of the age-distribution of neutralizing antibodies against the Lansing strain of poliomyelitis in three groups of the population of Israel. Two groups were chosen from the local population, and the third consisted of new immigrants from Yemen. Altogether 392 sera were examined, and the distribution of Lansing antibodies was found to be similar in the three groups. In the Yemen group and in one of the Israeli groups, 50% or more of the sera examined contained Lansing antibodies from the age of two years onwards; while in the second Israeli group this figure was reached at the age of three years. In the higher age-groups, 90-100% of the sera were Lansing positive. A correlation existed between the age specific rates of poliomyelitis during the 1950 epidemic in Israel and the age-distribution of Lansing antibodies found in this study. Comparative figures for Egypt and other parts of the world are discussed.

Entities:  

Keywords:  ANTIGENS AND ANTIBODIES; POLIOMYELITIS/immunology

Mesh:

Substances:

Year:  1955        PMID: 14379004      PMCID: PMC2542299     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

1.  IMMUNITY IN POLIOMYELITIS.

Authors:  W M Hammon
Journal:  Bacteriol Rev       Date:  1949-09

2.  Paralytic consequences of poliomyelitis infection in different parts of the world and in different population groups.

Authors:  A B SABIN
Journal:  Am J Public Health Nations Health       Date:  1951-10

3.  Age incidence and seasonal development of neutralizing antibodies to lansing poliomyelitis virus.

Authors:  T B TURNER; D H HOLLANDER; S BUCKLEY; U P KOKKO; C P WINSOR
Journal:  Am J Hyg       Date:  1950-11

4.  A survey of neutralizing antibodies to poliomyelitis virus in Cairo, Egypt.

Authors:  J R PAUL; J L MELNICK; V H BARNETT; N GOLDBLUM
Journal:  Am J Hyg       Date:  1952-05

5.  Development, persistence, and significance of type 2, poliomyelitis complement-fixing antibody in man.

Authors:  J CASALS; P K OLITSKY; A B SABIN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

6.  Transitory appearance of type 2 neutralizing antibody in patients infected with type 1 poliomyelitis virus.

Authors:  A B SABIN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

7.  Complement-fixing antibodies to type 2 (Lansing) poliomyelitis virus in a normal population of a subtropical area.

Authors:  N GOLDBLUM; J L MELNICK
Journal:  J Exp Med       Date:  1952-08       Impact factor: 14.307

  7 in total
  5 in total

1.  Epidemiological study of poliomyelitis in northern Israel, 1950-1956.

Authors:  D LEVY; W FALK
Journal:  Am J Public Health Nations Health       Date:  1960-06

2.  Some epidemiological aspects of poliomyelitis in Turkey; a serological survey for neutralizing and complement-fixing antibodies against polioviruses.

Authors:  S PAYZIN
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

3.  Poliomyelitis outbreak in Israel, 1950-1.

Authors:  P YEKUTIEL; E L LEVINGER; H V MUHSAM; M P YEKUTIEL
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

4.  Poliomyelitis in 1953.

Authors:  M J FREYCHE; A M PAYNE; C LEDERREY
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

5.  Epidemiology of poliomyelitis in Israel, 1952-59, with evaluation of Salk vaccination during a three-year period.

Authors:  A M DAVIES; K MARBERG; N GOLDBLUM; S LEVINE; P YEKUTIEL
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.